This function is often given to outside consultants that may not understand your organization and try to fit you into a cookie cutter vendor model.
You need to really understand that this is more than a form or checklist. Otherwise you may be missing great opportunities to add value and de-risk your organization.
Pharmaceutical and life sciences companies are under an extreme amount of pressure to maintain an ever-increasing amount of regulation and legislation. With this pressure, they still need to increase efficiencies, bring new products to the market faster, reduce prices, deliver innovation, ensure patient compliance, and maintain business compliance.
The European Medicines Agency's (EMA) Guideline on good pharmacovigilance practices (GVP), Module IV requires that risk-based audits of the quality system be performed at regular intervals to assure that it complies with the established quality requirements and to determine its effectiveness. It includes audit of the pharmacovigilance system which is covered by the quality system. The GVP Modules are applicable to EU-based companies and any company marketing medicinal products on a global basis. The legally required risk based audit strategy shall cover all PV processes and tasks undertaken by or delegated to other departments, MAH affiliates, and third parties such as distributors, external service providers, partners (the PV Universe). The PV Audit Strategy Plan is used to prepare the PV audit program, i.e. annual PV Audit Schedule.
On June 30, 2016, the Department of Justice (DOJ) along with the Department of Homeland Security (DHS) have issued several rulings outlining several civil penalties increases, ranging from small hikes to doubling penalties.
Not only does this ruling impact all immigration processes but it will impact the number of fines and penalties that employers must pay if they are audited for I9 documentation and impact most immigration processes and regulations.
Learn the precise way to correct I9 documents to stay away from non-compliance and penalties.
Today's workforce is experiencing high turnover and disengaged employees. It is a known fact that employees quit managers- to avoid turnover it is critical to have the appropriate skills to retain employees.
Transition from a Peer to Supervisor can be very difficult for most newly promoted supervisors. Many are not equip with the tools to successfully transition. This seminar will equip newly promoted supervisor with tools and techniques to decrease turnover, increase employee engagement and increase employee productivity.
If you go "off label" with advertising and promotion, FDA's hammer can hit hard and seemingly out of the blue. Advertising and promotion for devices is weak and lacks legal clarity. For drugs, the regulations are prescriptive and guidance documents clamp down on nuances. Marketing and regulatory affairs departments must collaborate to avoid the hammer and penalties of FDA. The roadblock, however is that marketing managers and regulatory affairs managers rarely reach common ground and are loathe to even consult with each other.
Learn how to prepare for an FDA inspection and how to behave during one by attending this webinar by Dr. Loren Gelber. Register Today.
Price:$200.00. Contact info : OnlineCompliancePanel Phn. no. +1-510-857-5896 Fax-+1-510-509-9659 email@example.com Event link -https://www.onlinecompliancepanel.com/webinar/How-to-Prepare-for-FDA-Inspections-and-Customer-Audits-of-Pharmaceuticals-505331/May-2019-ES-TRAININGREGISTRY
Learn about steam sterilization microbiology and how to develop a successful autoclave sterilization process. Register for the webinar today. Price:$200.00. Contact info : OnlineCompliancePanel Phn. no. +1-510-857-5896 Fax-+1-510-509-9659 firstname.lastname@example.org Event link -https://www.onlinecompliancepanel.com/webinar/Steam-Sterilization-Microbiology-and-Autoclave-Performance-Qualification-509267/May-2019-ES-TRAININGREGISTRY
After attending this 3-Hour Virtual Seminar, you will have great
understanding of how FDA and Customs and Border Protection (CBP)
operate a joint program.
Why should you Attend:
If you understand FDA's and CBP's import program, your business can
operate in a competitive way. If you do not, your customers, foreign
suppliers, stockholders will see the consequences and not be forgiving.
After completion of this course, attendees will have enhanced knowledge of the ever-changing landscape of Medical Device Regulation in the EU, Also The content of this course is designed to simplify the understanding of requirements and to provide attendees with the latest insight on how changes are being viewed and implemented by companies marketing products in the EU.
Failure to establish and keep required documentation exposes food
transporters to heavy fines and business closures.
Why should you Attend:
Understanding the new rules and building a sanitary transportation system is included in the FDA's FSMA hazard analysis risk-based preventive controls requirements for improved food safety during transportation processes.
In this webinar you will learn how to manage inspections efficiently and effectively, Also you will learn how to present information about your quality system in the most competent and professional manner, This webinar can help you prepare a strategy and detailed plans to more successfully prepare for, manage, and respond to an FDA or Notified Body Inspection.
The Drug Master File (DMF) is a valuable repository of confidential information which can be stored at the FDA by a product manufacturer in the pharmaceutical industry. The DMF summarizes the essential elements pertaining to facilities, processing, manufacturing components, packaging and storage for products associated with pharmaceutical product development. FDA guidance documents are available to assist with development of the DMF components, but translating the FDA regulations and guidance documents into actual practices reflecting current product development can be challenging. Expertise and diligence are required to determine which documents need to be created, stored and updated over time in the DMF at the FDA for support of marketing applications made by others using the company product.
Note: Use coupon code < REFERRAL10 > and get 10% off on registration.
The medical device field is one of the most heavily regulated industries, for obvious reasons. Medical devices are an important tool in efforts to improve patient care and treatment outcomes. Learn how to achieve more successful biocompatibility testing outcomes by attending this seminar.
Note: Use coupon code < REFERRAL10 > and get 10% off on registration.
The document management system for medical device industry should help companies have control over critical activities such as:
Establishing best practice SOP, Deviation, CAPA, Change Controls, Complaint and Audit processes
Conducting Risk Assessment, Root Cause Analysis and Impact Assessment where appropriate
Creating Action Plans, and verifying their effectiveness
Improving efficiencies over the QMS tasks
Reducing the risks of manual error
A recent MIT-Boston Consulting study of over 3,000 companies found that 80% of them believed AI (artificial intelligence) would give them a competitive advantage.
What's more, we are already seeing the use of AI and RPA (robotic process automation) creeping into the business world, and more specifically into various accounting functions.
This is one change that will radically impact many white-collar jobs. And that change will happen in the next few years, not ten or twenty years from now.
We'll begin by helping you ensure that your data is in the right shape to create a pivot table. This is the place most people stop on their journey.
Some of the fixes are so simple you'll be amazed. Then, onto actually creating pivot tables, understanding how they are connected and how they interact with the source data from which they are created.
From there, you'll learn how to activate features like GETPIVOTDATA functions, charts, graphs, calculated fields, filtering and sorting, and more!
Gaps, incorrect or incomplete implementation of safety functionality can delay or make the certification/approval of medical products impossible. Most activities cannot be retroactively performed since they are closely linked into the development lifecycle. Diligent, complete and correct implementation of risk management from the start of product development is therefore imperative. This course will introduce all necessary steps to design, implement and test critical medical devices in a regulatory compliant environment. This course will additionally address the software risk management and the resulting interfaces to device level risk management.
This Webinar will explain what 21 CFR Part 11 is, why it is important to FDA regulated companies and how conformance to Part 11 differs from just having good IT security. Procedures for controlling electronic signatures and electronic records as described in the FDA Guidance will be explained.
FDA regulated companies want to transition to electronic records for economy and efficiency. FDA, because of its concern for patient safety, wants to prevent electronic records from being compromised with possible resulting harm to the patient. FDA has set up regulations that address both data security and patient safety. We will show how 21 CFR part 11 considers both.
Packaging and Labeling form a bridge between the conception of a product and its realization and distribution, and consequently occupy a critical position in the success or failure of any pharmaceutical product launch or revision. Decision-makers need at least a cursory knowledge of potential pitfalls to create contingencies, as it is easier and more cost-effective to change things earlier in process than later.